retatrutide trials weight loss produces up to 30.3% in Phase 3 trial Experimental drug Retatrutide shows promising
Description
H., Hojrup, P
The second relates to the likely weight trajectory
In Jensterle et al
& Ou, Y
For all Foundayo dosages, month is defined as 30-days
Gavina P
